Glucomannn for the Treatment of Abdominal Pain-related Functional Gastrointestinal Disorders in Childhood Randomized Double Blind Placebo Controlled Trial
Sponsor study identifier
interventional
89
1 country
1
Study Start
January 2010
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
January 2012
Actual (reported)Study Completion
January 2012
Actual (reported)Background: Functional abdominal pain disorders (FAPD) are common in school-aged children; however, there is no reliable treatment. Aim: To determine the efficacy and safety of glucomannan for treating FAPD in children. Trial Setting: Department of Pediatrics, The Medical University of Warsaw. Intervention: Patients will be enrolled in a double-blind, randomized controlled trial in which they will receive either glucomannan (10g) or placebo for 4 weeks.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 2012
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 2010
Date type not reportedThis date has not been verified as actual or estimated.
July 12, 2011
Actual (reported)December 20, 2011
Actual (reported)January 2012
Actual (reported)January 2012
Actual (reported)number of patients with no abdominal pain at the end of the study
4 weeks (study period)
number of patients with improvement in self-reported severity of pain
4 weeks study period
number of patients suffered from abdominal pain < 1/week
4 weeks (during the study period)
number of patients who used medication for abdominal pain
4 weeks study period
number of patients who lost min.1 school day because of abdominal pain
4 weeks (study period)
Number of participants with adverse events as a measure of safety and tolerability
participants will be followed for the duration of h an expected average of 4 weeks - study period
5 g 2x 10 day
2 x 5g
glucose 5 g
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Dpt of Pediatrics Warsaw Medical University
Warsaw, Warsaw, 01-410, Poland
Horvath A, Dziechciarz P, Szajewska H. Glucomannan for abdominal pain-related functional gastrointestinal disorders in children: a randomized trial. World J Gastroenterol. 2013 May 28;19(20):3062-8. doi: 10.3748/wjg.v19.i20.3062.
Andrea Horvath, MD
Medical University of Warsaw
89 participants (actual enrollment reported by the registry).
First Submitted
July 12, 2011
First Posted
December 20, 2011
Study Start
January 2010
Date type not reportedThis date has not been verified as actual or estimated.
Effect of Glucomannan Supplementation on Body Weight in Overweight and Obese Children
Contact the study team to confirm eligibility.
Primary Completion
January 2012
Actual (reported)Study Completion
January 2012
Actual (reported)Last Updated
July 22, 2025
Record last verified: 2025-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: